New Pathophysiological Pathways Involved in Iron Metabolism Disorder in Heart Failure

NCT05000853 · clinicaltrials.gov ↗

UNKNOWN

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Iron Carboxymaltose

Sponsor

Hospital Universitari de Bellvitge